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Abstract
Background: Complex biomedical research can lead to disquiet in communities with limited exposure to scientific
discussions, leading to rumours or to high drop-out rates. We set out to test an intervention designed to address
apprehensions commonly encountered in a community where literacy is uncommon, and where complex biomedical
research has been conducted for over a decade. We aimed to determine if it could improve the validity of consent.
Methods: Data were collected using focus group discussions, key informant interviews and observations. We designed an
intervention that exposed participants to a detailed demonstration of laboratory processes. Each group was interviewed
twice in a day, before and after exposure to the intervention in order to assess changes in their views.
Results: Factors that motivated people to participate in invasive biomedical research included a desire to stay healthy
because of the screening during the recruitment process, regular advice from doctors, free medical services, and trust in the
researchers. Inhibiting factors were limited knowledge about samples taken from their bodies during endoscopic
procedures, the impact of endoscopy on the function of internal organs, and concerns about the use of biomedical samples.
The belief that blood can be used for Satanic practices also created insecurities about drawing of blood samples. Further
inhibiting factors included a fear of being labelled as HIV positive if known to consult heath workers repeatedly, and gender
inequality. Concerns about the use and storage of blood and tissue samples were overcome by a laboratory exposure
intervention.
Conclusion: Selecting a group of members from target community and engaging them in a laboratory exposure
intervention could be a useful tool for enhancing specific aspects of consent for biomedical research. Further work is
needed to determine the extent to which improved understanding permeates beyond the immediate group participating in
the intervention.
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Background
Successful recruitment and retention of subjects in clinical trials
contributes to both the statistical power and the credibility of a
trial [1]. However, this can be challenging in clinical trials which
involve invasive procedures, particularly those outside the most
familiar activities of medical care. Studies have shown that some
participants in clinical research are reluctant to take part in such
clinical trials because of misconceptions and fears regarding the
use of blood samples [2].
These concerns and misconceptions, which are often grounded
within a specific social-cultural context, generate rumours which
negatively affect recruitment and increase losses to follow-up [3].
Loss to follow-up can happen even after consent is obtained [4]
and may represent withdrawal of consent. For example, studies
conducted in Ghana and Zambia confirmed the role culture plays
in shaping perceptions and attitudes towards peoples’ involvement
in studies that involve drawing of blood samples [5,6]. Rumours
about blood thefts by ‘Satanists’ contributed to high losses to
follow-up in a trial conducted in Zambia on iron and multi-
micronutrient supplementation. This was as a result of ‘‘belief of
the existence of a cult which drinks human blood as part of their
rituals, and such collection of blood was generally viewed with
much suspicion’’ [6].
Discontent with the quantity of blood that people are requested
to give may also cause people not to participate in clinical trials or
withdraw from trials that involve drawing of blood samples [3].
Studies conducted in India showed that factors such as quality of
facilities, convenience of the facilities where samples are drawn,
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and the quality of service provided in these facilities, also
influenced people’s attitude towards blood donation [7–9]. Failure
to adequately explore and understand the underlying contextual
factors, for example social, cultural, economic and political issues,
regarding drawing of blood and tissue samples could adversely
affect programmes or laboratory investigations that require the use
of the blood and tissue specimens [3,10,11].
This study aimed at understanding the community’s perceptions
regarding involvement in complex biomedical research which
requires collecting blood and intestinal biopsy specimens for
advanced (non-routine) laboratory investigations in a community
in the southern part of Lusaka, Zambia. Over 30 years, Zambia’s
health systems have been stressed by the double burden of disease
(communicable and non communicable), and in particular the
health burdens of HIV infection which has a nationwide
prevalence of about 13.5% [12]. Previous studies have suggested
that biomedical research in Zambia, which often entails the
participation of people with little or no education in science-
related subjects, can lead to disquiet which leads to rumours or to
high drop-out rates [6,11]. In an attempt to enhance our
participants’ understanding of, and engagement in, our research,
we designed an intervention aimed at exposing participants to a
detailed demonstration of laboratory processes over the course of a
whole day. Here we report the results of an assessment of the
impact of this intervention on their understanding of, and
motivation to engage in, complex biomedical research in the
community where we carry out such studies.
Two research questions were addressed. First, what factors
motivate people to participate in a study which requires invasive
procedures such as drawing of blood and taking biopsy specimens?
Second, what factors might inhibit community members from
participating in a study which requires undergoing such invasive
procedures? We then assessed the impact of a laboratory exposure
intervention.
Methodology
The study design
The study used a qualitative case study methodology to
understand the community’s beliefs and perspectives about giving
blood and biopsy specimens for research purposes. The case study
methodology is an empirical approach that investigates contem-
porary phenomena within a real-life context; when the boundaries
between phenomena and context are not clearly evident; and in
which multiple sources of evidence are used [13]. The case study
approach was considered appropriate for the study because
research participants live within a complex context in a crowded
underprivileged neighbourhood, which involves social interactions
and relationships that subsequently influence the decisions
regarding involvement of individuals in clinical trials. Participants
in the current study were self-selected by volunteering during focus
group discussions which had been held as part of the consent
process for inclusion in a study of vaccines for diarrhoeal diseases
(ISRCTN89702061). We did not include people who did not
come forward for that study. In the previous/original study, the
participants were recruited following a house-to-house sensitisation
drive, then community discussions and face-to-face interviews.
Recruitment processes for this study followed procedures de-
scribed in previous publications [14,15].
Study Site
The study was conducted in Misisi compound, which is an
unplanned shanty area close to the city centre with an estimated
population of about 60,000 people. It is has a high housing density
with poor shelter, sanitation, roads, water supply and limited
health services. Like other compounds in Lusaka, the area is faced
with several health related problems which include cholera,
diarrhoea, malaria, cancer and HIV/AIDS. St. Lawrence health
facility is located in Misisi compound. The facility is located in a
church compound and is primarily orientated towards a large
community malnutrition/HIV programme for children.
Data collection methods
Focus Group Discussion. Four focus group discussions were
conducted with residents of Misisi Compound, a residential area
characterised by poor amenities, low socio-economic status, and
low literacy levels. The discussions were conducted at the
University Teaching Hospital, in the Department of Internal
Medicine. Only four FGDs were held because we reached a point
at which no new information was being obtained (data saturation).
Two FGDs had four participants while the other two had only
three participants. Having few people in the FGDs resulted in free
and searching discussions. In total 14 people participated in the
FGDs and the composition of the group is reflected in Table 1.
Less than half (6) of the participants had previously been involved
in a clinical trial. The FGD participants were aged from 20 years
to 60 years. Their education was modest in that none of them had
stayed in school beyond junior secondary school level (Grade 9).
Each group was interviewed twice in one day.
The FGDs were conducted by an independent social scientist
(JMZ) who had not been involved in the design or conduct of the
vaccine study. The social scientist had postgraduate training and
experience in qualitative research. No other people were present at
the focus groups besides the facilitator and the participants. To
ensure that no information was missed, the discussions were
recorded digitally.
FGD was selected as the main method of data collection. It has
proven to be a fast and efficient way of obtaining a wide variety of
information in a relatively short period of time. It is also an
effective way of gathering information on sensitive topics because
they enhance the disclosure of more data or material in three
ways: awareness of shared experience may encourage discussions
on difficult and sensitive issues; agreement between group
members can build an elaborated and fuller landscape of views;
disagreement between group members may lead participants to
defend their views and provide further explanation [16].
Two FGDs were conducted for each group. The first discussion
was held before the laboratory exposure intervention while the
second discussion was held after it. The first FGD focused on
understanding personal and community views regarding: 1) the
use to which biological specimens are put after collection, 2) issues
relating to storage of specimens, 3) willingness to donate specimens
among community members (including themselves), and 4)
barriers which inhibit participation in studies of this nature. Once
this was done, the participants were taken to the laboratory for the
intervention. The major focus in the follow up discussion was to
assess if there were changes in their views. An FGD guide
containing well outlined questions was used during the discussions
(Table 2). For each question, we asked about concerns relating to
blood and biopsy specimens. We also explored any changes in
views of the participants after going through the laboratory
exposure intervention.
Key informant interviews. Alongside these FGDs, three key
informant interviews were conducted with staff (one female and 2
male) that are directly involved in recruiting study participants in
the community. The staff are based at St Lawrence health facility.
The main purpose of the interviews was to validate the themes that
Informed Consent for Biomedical Research
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emerged in the FGDs by getting the views of the staff regarding
their experiences in recruiting study participants.
The laboratory exposure intervention. Participants, in-
cluding those who had previously donated specimens and those
who had not but had volunteered to participate in the vaccine
study, went through the intervention together. Non verbal as well
as verbal expressions clearly showed that the participants had a
keen interest in knowing more about the processes in the
laboratory, and most communicated that they greatly appreciated
being taken through the process. The intervention included
demonstrations of the following processes.
1. Processing blood: One of the participants volunteered to have
his blood drawn for demonstration. Blood was drawn into a
plain tube Vacutainer (Becton Dickinson). The purposes of the
different types of Vacutainers were also explained. The blood
was allowed to clot at room temperature then centrifuged for
serum separation. Using a Pasteur pipette the serum was
aliquoted into storage tubes labelled with a code, date and
sample type. It was explained that the codes were for
confidentiality.
2. Storing serum samples: The serum samples were then stored in
the 280uC freezer. The group was shown that samples were
stored by study and by year. It was explained and
demonstrated that some samples had been stored in the
freezer for up to 15 years.
3.Malaria screening: The procedure for malaria diagnosis using
thick and thin films was fully explained to the participants, and
participants were able to see different sorts of blood cells.
Venous blood was used from one of the participants who
voluntarily donated the blood sample. Reagents and materials
used were Giemsa stain, glass slides, applicator sticks,
immersion and a binocular microscope.
4. Storing biopsy specimen: The group was then shown biopsies
that had been taken from participants of a previous study. The
samples had been stored in formalin from a study in 2008.
Table 1. FGD Study participants.
FGD No.
Total No. of
participants
No. of female
Participants
No. of male
participants
Length of time of involvement
in the study – average
1 4 3 1 4 years
2 4 3 1 3 years
3 3 2 1 1 year
4 3 0 3 1 year
Total 14 8 6
doi:10.1371/journal.pone.0108305.t001
Table 2. Questions.
Sub topic Questions
Session One: Before the laboratory exposure intervention
Use of biological specimens 1. What do community members think biological specimens are used for after collection?
What do you think biological specimens are used for after collection?
Storage of specimens 2. What are community members’ views relating to storage of specimens?
What is your view relating to storage of specimens?
Willingness to donate specimens 3. What is your perspective regarding community members’ willingness to donate specimens?
What would you say about your willingness to donate specimens?
Motivation to donate specimens 4. What issues motivate community members to donate specimens?
What issues motivate you to donate specimens?
What issues motivate community members to participate in studies of this nature?
What issues motivate you to participate in studies of this nature?
Barriers to donating blood samples 5. What issues inhibit community members from donating specimens?
What issues inhibit you from giving specimens?
What issues inhibit community members from participating in studies of this nature?
What issues inhibit you from participating in studies of this nature?
Session Two: After the laboratory exposure intervention
Use of biological specimens 6. In which way has your view regarding what biological specimens are used for after collection changed?
Storage of specimens 7. How has your view relating to storage of specimens changed?
Willingness to donate specimens 8. What would say about your willingness to donate specimens?
Motivation to donate specimens 9. What is your comment regarding your motivation to donate specimens?
Barriers to donating blood samples 10. What is your comment regarding the barriers to donating specimens?
What is your comment regarding the barriers to participating in studies of this nature?
doi:10.1371/journal.pone.0108305.t002
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Data analysis
All FGDs were recorded digitally and later transcribed verbatim
by the first author. The first step in analysing data was the
development of codes. The first author developed initial codes
after reading the transcripts several times to develop a sense of the
whole dataset. The codes were shared with the second author
(MML, a biomedical scientist) for review. The authors separately
reviewed codes by systematically comparing it to the dataset to
arrive at the final code manual. Having agreed on the codes, the
coding process, which involved matching the codes with segments
of data selected as representative of the code, was carried out with
NVIVO version 7 (QSR Australia). Codes were then grouped into
categories – groups of content that share a commonality – and
these were then developed into themes through a process in which
all authors participated during the initial stages of developing the
manuscript [17]. This involved interpreting the categories for their
underlying meaning, and grouping categories according to
patterns as reflected in Table 3.
Data from the FGDs were then triangulated with other sources
such as the information gathered through observations during
laboratory processes and key informant interviews. Although the
process is presented as a linear process, it is important to stress that
this was an iterative process that involved continuous shifting back
and forth from participants’ narratives to the researcher’s
interpretation of what the informants meant [18]. The second,
third, fourth and fifth authors participated in the triangulation
process as they were responsible for conducting the observations.
This process involved assessing the consistency and potential
variations of findings by comparing data patterns across the
material generated by different methods. The triangulation
process showed that the major issues raised by participants such
as concerns on the effect of endoscopy on the internal organs of
the body as well as usage and storage of specimens were consistent
across the different types of data. Finally, the themes or results
were checked for validity during a meeting held in July 2013 at the
University of Zambia for participants in another study which was
attended by the key informants, members of the study team
(including all authors) and other stakeholders who were not part of
the study.
Ethical issues
Ethical clearance to conduct this intervention was obtained
from the University of Zambia Biomedical Research Ethics
Committee as part of the original application for the vaccine
study (UNZABREC 012-06-12). Written consent was obtained
from all focus group participants or volunteers giving blood,
including those who had provided consent in the earlier study.
Verbal consent was also sought from the key informants and
recorded using an audio recorder. Key informants did not provide
written consent. The verbal consent procedure was approved by
the ethics committee. Confidentiality, during and after the study
period was guaranteed such that FGD and key informant
responses, when reported to the PI and other study team
members, were not attributable to any specific individual.
Participation in the current study was voluntary. No financial
incentives or other gifts were offered to participants except for
transport refunds.
Table 3. Codes, categories and themes.
Codes Category Themes
-Living healthy lives
-Early detection of disease
Having a health body Motivation for participation in invasive biomedical
research
-Free medical screening
-Free medical support
Accessing free medical services
-Good research relationships
-Duration of involvement in studies
Trust between the study participants and
researchers
-Fears about of size of biopsy What do they remove from my body? Factors which might inhibit participation in invasive
biomedical research
- Limited awareness on use biopsy
- Involvement of non-African in the study
What do they do with my biopsy?
-Effect of intestinal endoscopy
-Misinterpretation of compensation
What happens to the body once the biopsy
is removed?
-Rumours about the specimens
- Misunderstanding of free medical services
-Concerns about quantity of blood
Blood used for satanic activities
-HIV status and repeated health care consultation Fear of being stigmatised as being
HIV positive
-Women more willing to participate
-Interference from husbands
-Men think research is time-wasting
Gender inequality and perceptual
differences
-Better understanding of quantity blood required
-Improved understanding of blood storage
-Seeing old samples increasing confidence and trust
Enhanced understanding of use
of specimens
Changes in perspective after the laboratory exposure
intervention
- Satisfaction with the security of storage –and
processing environment
- Reduction in fears and insecurities
-Commitment to sensitise the community
Increased willingness and confidence
to participate
doi:10.1371/journal.pone.0108305.t003
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Results
Social, economic, cultural as well as health related issues
influence people’s attitudes towards participating in clinical trials
that require invasive collection of biological specimens. In this
section, these issues have been grouped into two main categories,
namely motivating and inhibiting factors.
Motivation for participation in invasive biomedical
research
Having a healthy body. A dominant theme was that some
people agreed to participate in biomedical studies because it
helped them ‘‘live without falling sick’’. All discussants reported
that screening processes (always performed upon recruitment)
allows for early detection of any diseases they might have, and
enables them to adopt measures that will stop the disease from
progressing. Screening also leads to medical advice about lifestyle
and disease prevention, which study participants appeared to
value. One participant stated it was through her involvement in a
study that she learnt that she had a problem in the stomach which
was then addressed. Another participant reported that he had
been encouraged to continue participating in studies because it
was through such involvement that he learnt that he had
tuberculosis (TB).
‘‘If it was not for the study, I would have died. I had TB and
I got very sick. People suspected that I was HIV positive
because I was very slim. Thanks for the help from the
researchers.’’ (FGD 2, male participant 1).
Accessing free medical services. All the FGD participants
who had participated in previous biomedical studies indicated that
they were motivated to do so because participation guaranteed
them free access to a range of health services whenever they were
sick. Furthermore, they stated that once screened and found with a
health problem, they would have free medical support. The FGD
participants who had never previously participated in biomedical
research also reported that they had been inspired to seriously
consider participating in trials because of the desire for free
medical services, one of the benefits of such participation.
‘‘I have participated in giving blood and biopsy specimen
because we are given free treatment once we get sick. I think
this is what some members of the community admire.’’ (FGD 1,
female participant 3).
Key informant interviews also confirmed that participants
willingly participate in such studies because they hope to access
free medical services. Key informants stated that the majority of
those who participated in biomedical studies inquired about the
possibilities of accessing free medical services during the consent
process.
Trust between the study participants and
researchers. Trust between the researchers and study partic-
ipants seemed to be another motivating factor cited by the study
participants. This was raised by those who had participated in
previous studies. They reported that they had undergone more
than one intestinal endoscopy partly because of the good
relationship which they had developed with the Principal
Investigator. They reported that the research team had been
operating a clinic in their community/compound for more than
thirteen years, a situation which had made them trust their
activities.
‘‘We have worked with the doctor (Principal Investigator) for
more than five years. We trust him and this is why we give
him our blood whenever he asks for it.’’ (FGD 1, female
participant 1).
Inhibiting factors which might constrain participation in
invasive biomedical research What do they remove frommy
body? The FGD participants who had been involved in previous
studies did not express any concerns over giving of blood samples
for research purposes as they could actually see the blood being
drawn out from their bodies. However this was not the case with
regard to endoscopic procedures as the study participants are
given medication (sedation with benzodiazepines) which means
that they have no recall of what happened. This lack of awareness
has resulted in speculation about what it is that is taken from the
body, and more so the size of the biopsy taken. This has led to
some community members, even those who have never had an
endoscopy, insinuating that big pieces of flesh are removed from
the body leaving big sores where they have been taken from.
‘‘So my question has been: when they put the tube inside me,
what is it that they remove from inside my body-this is my
biggest anxiety?’’ (FGD 4, male participant 2).
What do they do with my biopsy? A dominant concern
related to the use to which the biopsy sample (‘kanyama’ in the
local language, translated into ‘flesh’ in English) would be put.
‘‘I have heard that when they put the tube inside the body, they
remove a piece of flesh (‘kanyama’), so my question is: what do
they do with the flesh?’’ (FGD 4, male participant 4).
In FGDs as well as key informant interviews, we delved into
some community beliefs about what they thought these samples
were being used for. One participant reported that it was
rumoured the samples are taken out of the country and used for
non-medical purposes such as fishing. Further discussions showed
that several FGD participants had come across someone who
believed in this view. The involvement of non- Africans in the
study, such as the Principal Investigator, was felt to contribute to
this concern. This is a belief of those when they do not know the PI
or key team members. While several of them admitted having
concerns regarding the use of the biopsies, most of the participants
did not explicitly state whether or not they believed in this view.
‘‘Lets be honest. In the compound, people say that they use the
flesh to catch shark in the ocean. They say that the shark has a
precious stone which attracts a lot of money once it is sold.’’
(FGD 1, female participant 2).
What happens to the body once the biopsy is
removed? Another concern raised, especially from those who
had undergone an intestinal endoscopy, was the effect the
endoscopy has on the internal organs of the body. They were
under the impression that the procedure would result in a wound
or sore in the intestine during or after the procedure. This came
about as a result of a discussion during one of the recruitment
meetings where they were informed that in the event that
something did go wrong during the endoscopic procedure they
would be compensated for any health complications that may
result from it. Some respondents interpreted this compensation as
for the wound which develops from the site of the biopsy.
Informed Consent for Biomedical Research
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However, they were quick to mention that at the same meeting,
they were told that previous studies had shown that the risk of
developing health complications was quite low.
‘‘The other concern is that, when you remove the flesh, what
remains there? Doesn’t this result in a wound? Then, if so,
does the same wound heal?’’ (FGD 3, male participant 1).
Blood used for satanic activities. Insecurities about draw-
ing of blood samples for use in studies resulted from the belief that
blood is used in the practice of Satanism and as such they feared
that their blood could be used for the same purposes. It was
reported that some members in the community believed blood
donors would end up experiencing misfortune in their families
such as sickness or death of their family member, as the process of
giving blood was perceived as an act of sacrificing the lives of
family members or of self. Although they acknowledged that not
everyone shared this view in the community, several of the
participants had been warned by community members not to
donate blood samples for the study because of Satanism.
‘‘Let me give an example, I had a girl who was in grade 12
and had a problem with her leg…., so the doctor (Principal
Investigator ) advised me that she be put on treatment. We did
that but unfortunately my child died.’’ ‘‘Do you know what
people said?’’ ‘‘They told me that my child died because I was
participating in the research activities, which are satanic.’’
(FGD 1, female participant 1).
It was further reported that some of the community members
substantiate this belief by suggesting that the free medical services
which some study participants access once they join the study are
actually payments given in exchange for the donated blood. Some
members of the community stated that researchers transport blood
outside the country for sale. While some FGD participants said
that they did not believe in such stories, others informed the group
that they were once part of groups which spread rumours that all
those who were part of such studies were Satanists. One
participant even mentioned the name of some of the individuals
that she had warned not to join studies as she believed that they
were practicing Satanism.
‘‘I used to say those people who give blood are Satanists. I
recall warning this one (pointing at another FGD partici-
pant) not to be part of the study. I told her that it is an activity
for Satanists.’’ (FGD 2, female participant 3).
Detailed analysis of responses suggests that these suspicions
often increase when people are required to give more than one
Vacutainer of blood. It was reported that they often wonder what
happens with the other tubes, as one small bottle should be
sufficient for doing tests. One FGD member stated that she had
been banned from participating in the women’s group at church
because the others believed that she practised Satanism by
donating blood for research activities.
Fear of being stigmatised as being HIV positive. In key
informant interviews, it was reported that potential participants
were afraid of being labelled as HIV positive. HIV is a common
reason for repeated health care consultation, so fear of stigma may
lead to avoidance of frequent attendance at health care facilities.
Gender inequality. Although the complexity of issues
surrounding undergoing an intestinal endoscopy as well as
drawing of blood apply to both sexes, all FGD participants and
key informants agreed that women were more willing to
participate in biomedical research than men. One possible reason
given was that it is mainly women who care for sick people and so
value activities aimed at improving health. Two FGD participants
reported that their husbands stopped them from undergoing an
intestinal endoscopy while one reported that her husband stopped
her from participating in a clinical trial until she developed a
health problem. The men explained that some men think that
participation in research is an unproductive way of using time as
men are supposed to spend time raising funds for the family.
Changes in perspective after the laboratory exposure
intervention
Enhanced understanding of use of specimens. Having
been shown what happens to blood samples once they reach the
laboratories, all participants indicated that they now understood
why at times they are required to donate more than one bottle of
blood or why blood is stored for some time in the laboratory.
Furthermore, fears about where and how the samples are stored
were quickly overcome. Participants stated that seeing old samples
being properly refrigerated was proof enough that samples were
not being exported for sale. As participants were being shown the
stored samples, especially biopsies, one could easily observe that
they were surprised that it was possible to keep samples for such a
long time. Some participants seemed relieved that the biopsy
specimen was smaller (actually about 361 mm) than was being
projected by some members of the community. One of the
participants openly showed her excitement upon seeing the biopsy
specimen which was taken from her close to five years before. The
participant recognised that the code on the biopsy was hers.
‘‘Yes, this is my code… I can’t believe what am seeing!… this
was taken a long time ago from my stomach… so what people
have been telling us that these people misuse samples is not
true.…rumours can mislead someone.’’ (FGD 1, female
participant 1).
Increased willingness and confidence to
participate. When FGD participants saw how the samples
were being processed and stored in a secure environment they
stated that they would consent more freely to future biomedical
research. Those who had never previously been involved in such
studies (but had already given consent to the vaccine study and
were waiting for their turn in endoscopy) indicated that they were
now more than before ready to undergo an intestinal endoscopy.
This attitude was a sharp contrast to their attitude before being
taken to the laboratories, which was characterised by doubts and
hesitations. For those who had been involved in such practices
before, they stated that the process further strengthened their
desire to continue being part of such activities. Most importantly,
they acknowledged that this had erased most of their fears and
insecurities about blood and biopsy specimen. Most participants
went as far as to suggest that they would all commit themselves to
go and dispel the rumours and misconceptions about the use of
blood and biopsy samples.
‘‘I am now ready to give my biopsy (kanyama) for the study…,
it is actually a tiny thing… nothing much to worry about. I do
not just want to be giving those urine samples.’’ (FGD 1,
female participant 3).
Informed Consent for Biomedical Research
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Discussion
The paper has discussed the dynamics that shape people’s
attitudes towards giving of blood samples in Misisi compound of
Lusaka. Cultural interpretations, religious values, social stigmatisa-
tion and health concerns are some of the main issues which shape
people’s attitudes towards consenting to participate in invasive
biomedical research and clinical trials. We have obtained clear
evidence that immersion of participants in a laboratory for a full
day, followed by group discussions, can enhance understanding of
certain biomedical procedures. Notwithstanding that most of our
participants have little or no scientific education and a few cannot
read in any language, the demonstration of key processes and
samples had a strong demystifying effect. The reassurance
provided was palpable, and it is our belief that the enhanced
understanding of laboratory practices can only enhance the
validity of consent, hinging as it does on comprehension of what is
really involved.
Culture, which is often learnt through the process of socialisa-
tion, plays a great role in defining and moulding people’s
behaviour and attitude. ‘‘Within the environment into which the
child is born, he learns the language, customs attitude and the
various ways in which things are done in his society by observing
his surroundings’’ [19]. These beliefs certainly include perceptions
relating to blood. Tissue biopsies are a modern phenomenon, but
nevertheless when there is an information gap, rumours will
develop to fill that gap.
There are many rumours about blood in Africa, which have
been shaped by different histories and political, social and
economic structures within countries [20]. Blood is often viewed
as sacred. It is only in living memory that it has become accepted
that it can be drawn out of the body under special circumstances
for example during medical examination when a person is sick [3].
It is for this reason that respondents in this study expressed fear of
donating blood and tended to associate the practice with Satanism.
This finding resonates with other reports of fear that researchers
use blood samples for rituals, and blood collection is viewed with
suspicion in some African communities. Such rituals would have
the potential of creating misfortunes in families of those involved,
and this understandably generates fear [3].
Beliefs about certain practices define social relations and
influence how people react towards certain activities in the
community. It is important to note that acting outside culturally
defined behavioural norms usually results in being labelled a
‘deviant’ [19]. Such a label would attract social discrimination and
subsequently loss of social support. This could explain the
experience of the woman who was reportedly excluded from
church activities for participating in a biomedical research study.
Such exclusion from family, community or religious activities
would create severe insecurity in individuals in most African
countries where socio-cultural networks are strong, and ‘‘the
individualism as a way of being has little or no place in societies
which have strong sense of kin and community ties, where
individuals meet their needs on the basis of shared morality of
claims and obligations’’ [21]. Several people define their identity
and social support ‘‘by participating in the identity of a collectivity.
This identification is often expressed in exalted, mystical terms.
The real me is joined to the spiritual life of a community’’ [22].
For, Zambia, one of the key collective issues is religion, as Zambia
is predominantly Christian [23]. Some religions such as Jehovah’s
Witnesses believe that the Bible prohibits blood donation and
transfusion [24]. Fear of exclusion encourages conformity to
cultural norms and values [19], a situation which, if not fully
understood and addressed, has the potential of negatively affecting
giving of informed consent for clinical trials.
Fear of negative effect on health is a major constraint on
willingness to participate. In one FGD it was reported that a
woman’s daughter’s death was attributed to her involvement in a
research study. Helman [25] notes that in non-Western societies,
illness maybe due to the active intervention of an agent, such as a
supernatural being (a god) or human being (witch or sorcerer). For
instances, in a number of societies, the out-break of a disease with
no cure or origin may be attributed to the committing of an
offence against one’s spirits, the ancestors or the gods, or an
omission of duty on the part of the infected person [26,27]. For
example, at different times in Ghana, the outbreak of diseases such
as tuberculosis, measles and guinea worm has been attributed to
supernatural causes [28]. It has been stated that ‘‘the invocation of
‘witchcraft’ provides ways of answering the questions: why me? or
her/him?’’ [29]. Self-perception of being unwell, which in the
context of this study include the fear that the biopsy may create a
wound in the body [30], may also negatively affect giving of
informed consent in studies.
Apart from communities being anxious that blood would be
used for ritual activities, our findings suggest that involvement of
non Africans in studies can exacerbate concerns that biological
specimens could be transported out the country and used in
business transactions. These concerns are not unique to this study
as other workers have found that resistance to participation in
clinical trials was more pronounced if the community perceived
the African researchers as associated with ‘white’ researchers [31].
Stigmatisation by association with HIV may be another
constraint. Respondents stated that the processes for testing of
blood in biomedical studies was compared to HIV testing
processes by several community members. Regular attendance at
health facilities was likened to regular check ups that people who
are living with HIV go through. Banteyerga et al., note that HIV/
AIDS stigma exists and that it has an effect on the choices that
people make including health seeking decisions. HIV/AIDS
stigmatisation, according to Banteyerga et al. [32] takes different
forms, which include ‘‘verbal,’’ for example laughter or ridicule;
‘‘social exclusion,’’ such as loss of social security or belonging; and
‘‘loss of identity,’’ which encompasses shame or existential and
cultural insecurities. It is a mark of underperformance by local
health services that HIV is perceived as the only legitimate reason
for regular health care, and long term care for non-communicable
disease, which should be the norm in the health sector, is regarded
as exceptional. While much progress has been made in reducing
the HIV stigma, clearly much more needs to be done. This sort of
constraint could probably not be expected to respond to a
laboratory exposure intervention, and indeed this is what we
found.
Gender inequalities may also affect the giving of informed
consent. One of the cultural issues surrounding masculinity and
femininity include the need for permission for women from men,
more so in the case of couples, before participating in clinical trials.
Some women, especially those who are married, had difficulty
getting support from their husbands who would not allow them to
participate. Several studies in Africa have shown that a real man is
supposed to exercise authority over women or risks being
perceived as not ‘man enough’ [33]. As with HIV, this constraint
did not respond to our intervention.
Other factors which have been documented, though not
captured in our discussions include fear of hospitals, unpleasant
experiences following blood draws, fear of needles, and pain [30].
A study in India showed that the most common reason for not
donating blood was the perception of a harmful effect of donation
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on the body. Cultural beliefs were however not commonly cited as
factors although the respondents mentioned that collecting blood
from children and pregnant women could lead to serious health
consequences. Several respondents questioned why blood would
be taken from participants who were not sick [9]. On the other
hand, this might explain why the spacious and clean dedicated
facilities in which they are seen for the purposes of the study might
encourage people to participate.
Overall, the participants in this study, like other studies [30],
showed a lack of awareness of the processes of drawing blood and
taking biopsy specimens, storage of samples, and usage of the
specimen as causes of fears and misconceptions about participating
in studies that require invasive procedures. The intervention we
implemented had a dramatic effect on these anxieties. This
resonates with Boahen et al. [3] ’s view that it is important to
complement oral explanations with a visual presentation explain-
ing what the blood-draw procedure entails and the uses if people’s
ability to give informed consent are to be improved. We have not
ascertained the extent to which the effect of our laboratory
exposure intervention could be replicated by a video demonstra-
tion, but our impression was that the immediacy of the immersion
we used might have an impact beyond the purely visual.
Strengths and Limitations of the Study
The strength of the study was enhanced through the use of
multiple methods to collect data. Triangulating data collection
methods helped in developing an account that is rich and
comprehensive [34]. Credibility of the findings was enhanced
through thoroughly documenting the research process, transcrib-
ing and reviewing all interviews. In addition sharing the results
with the key informants, members of the study team and others
stakeholders who were not part of the study during a meeting
related to another study held in July 2013 at the University of
Zambia helped in clarifying the findings [34] and also provided
additional data [35]. Our findings cannot be generalized to high
income and more educated groups, as the participants in our study
were all drawn from the disadvantaged community living in Misisi.
The other limitation is that the study sample size was small and it
is also possible that the sample of participants included in the study
are those most likely to be interested in participating in this sort of
research. Despite these limitations, the inclusion of key informants
who were responsible for recruiting participants for the original
study as well as questions regarding FGD participants’ perspectives
of factors that facilitate or inhibit other community members from
giving consent provided some insights which could apply to some
of the people who may not have been interested in participating in
the study. In general, the rich description of phenomena [36],
factors that motivate and hinder people from giving blood and
biopsy specimen, contributes to the knowledge base on improving
informed consent and may provide a basis for analytic general-
izations that could provide useful insights in similar settings.
Conclusion
We have found that peoples’ ability to provide informed consent
in studies that require the use of blood and biopsy specimen is
shaped by various contextual factors, some of which may beyond
an individual’s capacity. These include the desire to access free
health services, being aware about ones’ health status and
adopting healthier lifestyles based on the advice from doctors.
However, limited knowledge regarding what happens during the
processes of giving blood and biopsy specimen, cultural beliefs/
concerns about the use of the samples (.e.g. rumours that blood is
used for satanic activities and biopsies for fishing sharks), gender
inequality as well as fear of social stigmatisation and loss of social
support were some of the factors which may inhibit full
participation.
We observed that taking participants though the various
laboratory processes significantly changes peoples’ attitudes
towards giving blood and biopsy specimen by increasing awareness
levels about not only the laboratory processes but also the benefits
associated with giving specimen. We propose that selecting a
group of members from target community and engaging them in a
laboratory exposure intervention can be a useful addition to
consent processes for biomedical research in communities with low
scientific exposure. This could be followed by appropriate
motivational campaigns based on the input from the study
participants aimed at addressing concerns within the community.
This is a potential tool for enhancing consent for biomedical
research in developing countries which will be needed for
developing approaches to emerging health problems, new and
old. We therefore recommend an additional longitudinal analysis
to see the effects of the intervention for other future participants.
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